Intelligent Investor

Suda Pharmaceuticals Ltd (ASX: SUD) - Announcements

- Current share price for SUD : $0.048

ASX company news and announcements for Suda Pharmaceuticals Ltd (SUD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Suda Pharmaceuticals Ltd (SUD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Suda Pharmaceuticals Ltd (SUD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Suda Pharmaceuticals Ltd (SUD)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- SUDA becomes Arovella Therapeutics 22 Oct 2021 8:20AM $0.048 $0.048 $0.047 fallen by 0%
- Chile Ministry of Health Approval Granted for ZolpiMist 21 Oct 2021 10:00AM $0.049 $0.048 $0.047 fallen by 2.04%
- Results of General Meeting 14 Oct 2021 1:51PM $0.046 $0.048 $0.047 risen by 4.35%
- GM presentation 14 Oct 2021 9:33AM $0.047 $0.048 $0.047 risen by 2.13%
- Appendix 4G and Corporate Governance Statement 2021 30 Sep 2021 3:59PM $0.048 $0.048 $0.047 fallen by 0%
- Annual Report to shareholders 30 Sep 2021 3:58PM $0.048 $0.048 $0.047 fallen by 0%
- Notice of Extraordinary General Meeting/Proxy Form 15 Sep 2021 10:14AM $0.052 $0.048 $0.047 fallen by 7.69%
- Investor Presentation 7 Sep 2021 8:54AM $0.057 $0.048 $0.047 fallen by 15.79%
- Dr John Maher Appointed to SUDA iNKT Cell Therapy SAB 3 Sep 2021 9:04AM $0.055 $0.048 $0.047 fallen by 12.73%
- Preliminary Final Report 31 Aug 2021 10:46AM $0.048 $0.048 $0.047 fallen by 0%
- Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SAB 26 Aug 2021 9:38AM $0.045 $0.048 $0.047 risen by 6.67%
- SUDA signs Licence and Distribution Agreement with STADA 24 Aug 2021 10:43AM $0.047 $0.048 $0.047 risen by 2.13%
- ZolpiMist Update 23 Aug 2021 3:33PM $0.048 $0.048 $0.047 fallen by 0%
- iNKT cell therapy platform update 16 Aug 2021 9:54AM $0.050 $0.048 $0.047 fallen by 4%
- Initial Director's Interest Notice 12 Aug 2021 9:47AM $0.053 $0.048 $0.047 fallen by 9.43%
- Appointment of Dr Debora Barton as Non-Executive Director 10 Aug 2021 8:18AM $0.052 $0.048 $0.047 fallen by 7.69%
- SUDA appoints new cell and gene therapy manufacturing expert 2 Aug 2021 8:53AM $0.049 $0.048 $0.047 fallen by 2.04%
- SUDA to present at NWR Virtual Investor Conference 29 Jul 2021 9:52AM $0.049 $0.048 $0.047 fallen by 2.04%
- Quarterly Appendix 4C and Activities Report 26 Jul 2021 10:13AM $0.053 $0.048 $0.047 fallen by 9.43%
- Notification regarding unquoted securities - SUD 13 Jul 2021 5:54PM $0.066 $0.048 $0.047 fallen by 27.27%
- Application for quotation of securities - SUD 29 Jun 2021 4:31PM $0.055 $0.048 $0.047 fallen by 12.73%
- Proposed issue of securities - SUD 22 Jun 2021 4:10PM $0.052 $0.048 $0.047 fallen by 7.69%
- Disclosure Document Prospectus $3.65m 22 Jun 2021 10:10AM $0.036 $0.048 $0.047 risen by 33.33%
- Proposed issue of securities - SUD 22 Jun 2021 10:10AM $0.036 $0.048 $0.047 risen by 33.33%
- SUDA Placement Raises $3.65m 22 Jun 2021 10:10AM $0.036 $0.048 $0.047 risen by 33.33%

1 - 25 of 445 results

Page 1 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.